Skip to main content

Sreekanth Vemulapalli

Associate Professor of Medicine
Medicine, Cardiology
Box 3126 Medical Center, Durham, NC 27710
2301 Erwin Rd, Room 7451 D, Durham, NC 27710

Current Appointments & Affiliations


Associate Professor of Medicine · 2025 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 2016 - Present Duke Clinical Research Institute, Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy · 2024 - Present Duke-Margolis Institute for Health Policy, University Institutes and Centers

In the News


Published April 4, 2019
Hospitals That Perform More Heart TAVR Surgeries Have Better Success. That's Important for Medicare Policy

View All News

Recent Publications


Early outcomes of off-label transcatheter tricuspid valve repair/replacement in the STS/ACC TVT registry.

Journal Article Am Heart J · May 2026 BACKGROUND: Transcatheter tricuspid valve interventions (TTVI) have expanded with the recent FDA approval of both replacement transcatheter tricuspid valve replacement (TTVR) and edge-to-edge repair (T-TEER) devices. However, the volume and outcomes of com ... Full text Link to item Cite

Sex and Racial Disparities in Outcomes of Transcatheter Edge-to-Edge Mitral Valve Repair for Functional Mitral Regurgitation: A Multicenter Prospective Analysis.

Journal Article Struct Heart · May 2026 BACKGROUND: Functional mitral regurgitation (FMR) is associated with poor heart failure (HF) outcomes. Mitral transcatheter edge-to-edge repair (M-TEER) is recommended for symptomatic patients despite medical therapy, though the influence of sex and race o ... Full text Link to item Cite

Tricuspid Valve Academic Research Consortium-2 (TVARC-2) Tricuspid Valve: Trial Design and Endpoints.

Journal Article J Am Coll Cardiol · April 21, 2026 The first Tricuspid Valve Academic Research Consortium publication standardized definitions of disease etiology and severity, as well as standardized endpoints for trials to address the knowledge gaps related to identification and management of patients wi ... Full text Link to item Cite
View All Publications

Recent Grants


2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2023 - 2030

2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029

View All Grants

Education


Duke University, School of Medicine · 2005 M.D.